Quantcast
Last updated on April 17, 2014 at 8:56 EDT

Latest Avodart Stories

2013-01-02 05:03:25

According to court documents, on December 6th, 2012, a Texas resident and his wife filed a lawsuit in Pennsylvania Eastern District Court alleging he developed prostate cancer from his use of the drug Avodart. In light of these news, AttorneyOne, a recognized authority on law, informs that they are now providing advice, including how to get in contact with legal counsel, to people potentially affected by Avodart side effects. San Diego, CA (PRWEB) December 31, 2012 AttorneyOne.com, a...

2012-03-27 23:00:56

On March 19th, 2012 Health Canada issued a warning about Avodart, and other drugs used to treat enlarged prostate, that they may be associated with an increased risk of developing a serious form of prostate cancer known as high-grade prostate cancer, an aggressive type of prostate cancer. Avodart (dutasteride), manufactured by GlaxoSmithKline, was approved by the FDA in October 2002 for the treatment of urinary problems. The medication, in use for men only, helps improve urinary flow and may...

2011-06-20 15:01:00

PARSIPPANY, N.J., June 20, 2011 /PRNewswire/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI) today confirmed that its subsidiary, Watson Laboratories, Inc. - Florida, filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market Dutasteride Capsules, 0.5 mg. Watson's Dutasteride Capsules product is a generic version of GlaxoSmithKline's AVODART(R), which is indicated for the treatment of symptomatic benign prostatic hyperplasia...

2010-12-01 00:33:35

Office-based primary care doctors rank GSK's sales force number one, a jump from third in 2009. Pfizer finished second and Merck placed third this year. Plymouth Meeting, PA (Vocus) November 30, 2010 According to SDI's 2010 Ranking Tables Study, office-based primary care physicians "“ general practitioners, family medicine physicians, and doctors of osteopathy "“ rank GlaxoSmithKline's sales force number one, a jump from third in 2009. Pfizer finished second and Merck placed...

2008-06-20 09:00:06

GlaxoSmithKline has announced that the FDA has approved Avodart in combination with tamsulosin for the treatment of symptomatic enlarged prostate, a disease that is said to affect half of all men over 50 years old. The FDA approval was based on two-year results of the CombAT study, one of the largest clinical trials to date of men with enlarged prostate. The CombAT study is the first long-term assessment of the combination of Avodart and an alpha-blocker, the company said. The CombAT...

2008-06-19 21:00:09

PHILADELPHIA, June 19 /PRNewswire-FirstCall/ -- GlaxoSmithKline today announced that the U.S. Food and Drug Administration (FDA) has approved AVODART (dutasteride) in combination with tamsulosin for the treatment of symptomatic enlarged prostate, a disease that affects half of all men over 50 years old. The new indication reflects emerging research showing the combination of the two medicines treats the symptoms of enlarged prostate more effectively than either medicine alone. "The...